Silver Nanoparticle Antibiotic Composites for Resistant Bacteria

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The rising issue of antibiotic resistance in bacterial infections poses a significant challenge in treating infections effectively, as current antibiotics become less effective, leading to increased medical costs, prolonged hospital stays, and higher mortality rates, necessitating the development of new treatments.

Innovation Solution

The use of metallic silver nanoparticles supported on inert carriers or antibiotics, combined with traditional antibiotics, to enhance antimicrobial efficacy against resistant bacterial strains, with the nanoparticles being prepared through a process involving silver ion dissolution and reduction on the carrier, allowing for effective interaction and improved treatment outcomes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional antibiotics are used to treat bacterial infections, then the treatment is effective against susceptible bacteria, but the effectiveness decreases against antibiotic-resistant bacteria

Engineering Contradiction:

Improveantibiotic effectivenessVSAvoidbacterial resistance

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines silver nanoparticles with traditional antibiotics to create a dual-action treatment system. The silver nanoparticles work through multiple mechanisms (membrane disruption, oxidative stress, protein denaturation) that are independent of conventional antibiotic pathways, thereby overcoming bacterial resistance while maintaining the antibiotic's efficacy against susceptible strains.

Inventive Principle:

Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite antimicrobial system where silver nanoparticles are integrated with antibiotic molecules. This composite approach allows the combination of physical disruption mechanisms (silver) with biochemical mechanisms (antibiotics), addressing both susceptible and resistant bacterial strains through synergistic action.

Inventive Principle:

Principle #40Composite materials

2Reliability

If higher doses of antibiotics are used to overcome resistance, then the antimicrobial effect is enhanced, but the development of resistance and harmful side effects increase

Engineering Contradiction:

Improveantimicrobial effectVSAvoidresistance development and side effects

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the mechanism of action parameters by introducing silver nanoparticles that operate through completely different pathways than traditional antibiotics. This parameter diversification allows effective treatment at lower antibiotic doses, reducing selective pressure for resistance development while minimizing toxic side effects.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

Silver nanoparticles act as an intermediary mechanism that bypasses bacterial resistance pathways. They provide an alternative route to achieve bacterial cell death through physical and chemical mechanisms (membrane disruption, ROS generation) that are not affected by antibiotic resistance mechanisms, thereby reducing the need for high antibiotic doses.

Inventive Principle:

Principle #24Intermediary (Mediator)

3Adaptability or versatility

If silver nanoparticles are used alone as antimicrobial agents, then they show broad-spectrum activity, but their efficacy is limited compared to combination therapy

Engineering Contradiction:

Improvebroad-spectrum activityVSAvoidantimicrobial efficacy

Core Design Contradiction:

Adaptability or versatilityVSReliability

Solution Approach 1:

The patent merges the broad-spectrum capabilities of silver nanoparticles with the targeted mechanisms of specific antibiotics. This combination creates a synergistic effect where the silver nanoparticles provide broad coverage while the antibiotic delivers potent targeted action, resulting in enhanced overall efficacy beyond what either agent could achieve alone.

Inventive Principle:

Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach demonstrates enhanced antimicrobial activity against resistant bacterial strains, potentially reducing antibiotic resistance by allowing lower doses of antibiotics to be effective, thereby minimizing resistance development and improving treatment efficacy.

Implementation Method 1

The nanosystem comprises silver nanoparticles which are supported on a carrier

Methodology Applied

Scientific EffectReduction: Reduction

Data Source

PatentUS11304974B2Nanosystems comprising silver and antibiotics and their use for the treatment of bacterial infections

Publication Date: 2022.04.19 LAB ENOSAN SL

AI summary

A composition including metallic silver nanoparticles is supported on a carrier, wherein the carrier is in the form of particles. The carrier is selected from an inert carrier or an antibiotic. The composition further includes at least one antibiotic in the case the carrier is an inert carrier. A related nanosystem includes a composition having metallic silver nanoparticles or a mixture of silver nanoparticles and at least one antibiotic for use in the treatment of an infection caused by at least one strain of bacteria resistant to at least one antibiotic. Pharmaceutical compositions and methods for the preparation of these compositions and nanosystems are also used for the treatment of bacterial infections.